BRITISH JOURNAL OF CANCER-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-09-18 nenee 来自湖北省

偏重的研究方向：乳腺癌;肿瘤
经验分享：请问under consideration 两周了是怎么回事呢

16 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2021-06-10 godweiZ

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：食管癌
经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。

130 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2022-06-23 ms3000000859573514

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤治疗
经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火

74 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2020-01-08 18900911270haoliangdut

请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表:
有救

138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救

149 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-08-27 docL 来自上海

偏重的研究方向：分子标记物
经验分享：100天了，还没找到审稿人

18 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2022-09-12 Glori

审稿速度:3.0
偏重的研究方向：肿瘤
经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久

69 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-02-16 ms1000001023607781 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤样本测序数据分析
经验分享：Stage Start Date
Decision made 7th Jan 23
Under review 12th Sep 22
Under consideration 30th Aug 22
Author Approved Converted Files 30th Aug 22
Under submission 29th Aug 22
审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！

33 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-08-23 火辣辣的夏天来自重庆

偏重的研究方向：肿瘤
经验分享：这个杂志投稿时对格式要求严格吗

16 0

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2022-10-26 Glori

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤微环境
经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！

48 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2158253, encodeId=d70a215825312, content=偏重的研究方向：乳腺癌;肿瘤 经验分享：请问under consideration 两周了是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XsHTcldMwNr9qJg8licZ3E3iblE2WGy8a0HZK7S2ia6N25wVmXiaIaLzJ1ztdiadf5mb7W1Ky9MwibEEKIhQQ9U2NYfQ/132, createdBy=64b21729881, createdName=nenee, createdTime=Mon Sep 18 09:56:48 CST 2023, time=2023-09-18, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=972453, encodeId=6c809e245366, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：食管癌 经验分享：2021年1月4日投稿，1月11日under review，3月5日一审意见返回要求补一些实验，5月11日修回，5月27日accept in principle。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a2cb5509177, createdName=godweiZ, createdTime=Thu Jun 10 11:05:10 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228175, encodeId=486c12281e5d4, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤治疗 经验分享：综述审稿2个月小修建议5条，补了一个图。后面就接收了。但是后面付彩图钱的时候，连接总是打不开，就很恼火, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1368213680, createdName=ms3000000859573514, createdTime=Thu Jun 23 10:09:47 CST 2022, time=2022-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582909, encodeId=75ec58290922, content=请问现在什么阶段了？我的是under consideration 20天，现在是under review，现在就是审稿阶段吗？138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, beContent=138****0604暂无昵称 2019-11-16 00:00:00 发表: 有救, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/26/0edec3934014b65cf886896ae28cc170.jpg, createdBy=e5735234802, createdName=18900911270haoliangdut, createdTime=Wed Jan 08 00:00:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154793, encodeId=703a2154e934e, content=偏重的研究方向：分子标记物 经验分享：100天了，还没找到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94441709139, createdName=docL, createdTime=Sun Aug 27 14:55:21 CST 2023, time=2023-08-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1248515, encodeId=1d2f124851592, content=审稿速度:3.0 偏重的研究方向：肿瘤 经验分享：2022.07.21 Under review，2022.09.12号还是Under review，已经接近两个月了，不知掉还要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Mon Sep 12 16:53:23 CST 2022, time=2022-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2114906, encodeId=87502114906ca, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤样本测序数据分析 经验分享：Stage Start Date Decision made 7th Jan 23 Under review 12th Sep 22 Under consideration 30th Aug 22 Author Approved Converted Files 30th Aug 22 Under submission 29th Aug 22 审稿4个月，最后编辑说没找到审稿人，然后直接拒了...很坑...白白浪费了4个多月的时间！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a8478305607, createdName=ms1000001023607781, createdTime=Thu Feb 16 13:35:14 CST 2023, time=2023-02-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2154267, encodeId=ed97215426e13, content=偏重的研究方向：肿瘤 经验分享：这个杂志投稿时对格式要求严格吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLB5IibH2PUWVTzgeyj5CYBLvgXTqukVIpibqw6yX6he1EMdh9HeJowqEalFjIPBMibeJw9CVqu0EBibDQ/0, createdBy=3b872068795, createdName=火辣辣的夏天, createdTime=Wed Aug 23 19:54:29 CST 2023, time=2023-08-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2096293, encodeId=dbbe209629351, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤微环境 经验分享：请问一轮审稿后，编辑给了rejected with opportunity for resubmission，我预估要补两个月实验；这种情况下我是否需要先给编辑发邮件表明自己想重投，亦或是自己完全按照审稿人意见改好了之后再写信并重投呢；大家有没有经验，谢谢分享！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoAlkIjytYG8O8o9NLygo13F23UBLUbiam2DIibCXIeprMLP9CYYLTnEh4qQdw23ibjoibibYkwQtKu7ibg/132, createdBy=42f31730574, createdName=Glori, createdTime=Wed Oct 26 16:44:29 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2139001, encodeId=cb7a213900173, content=收回顾性文章吗......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Thu May 25 15:37:45 CST 2023, time=2023-05-25, status=1, ipAttribution=上海)]

2023-05-25 阿曾曾曾曾来自上海

收回顾性文章吗.......

35 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务